214 related articles for article (PubMed ID: 7904756)
21. Characterization of the human dopamine D3 receptor expressed in transfected cell lines.
MacKenzie RG; VanLeeuwen D; Pugsley TA; Shih YH; Demattos S; Tang L; Todd RD; O'Malley KL
Eur J Pharmacol; 1994 Jan; 266(1):79-85. PubMed ID: 7907989
[TBL] [Abstract][Full Text] [Related]
22. Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function.
Huang Y; Qiu AW; Peng YP; Liu Y; Huang HW; Qiu YH
Neuro Endocrinol Lett; 2010; 31(6):782-91. PubMed ID: 21196914
[TBL] [Abstract][Full Text] [Related]
23. Dopamine D-2 autoreceptors regulating the release of dopamine from cultured rat fetal dopaminergic neurons do not desensitize upon sustained activation: implications for the combined pharmaco- and grafting therapy in parkinsonian patients.
Van Muiswinkel FL; Drukarch B; Steinbusch HW; Stoof JC
Exp Neurol; 1994 Feb; 125(2):218-27. PubMed ID: 7906226
[TBL] [Abstract][Full Text] [Related]
24. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
Levant B; Grigoriadis DE; DeSouza EB
J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist.
Merchant KM; Gill GS; Harris DW; Huff RM; Eaton MJ; Lookingland K; Lutzke BS; Mccall RB; Piercey MF; Schreur PJ; Sethy VH; Smith MW; Svensson KA; Tang AH; Vonvoigtlander PF; Tenbrink RE
J Pharmacol Exp Ther; 1996 Dec; 279(3):1392-403. PubMed ID: 8968364
[TBL] [Abstract][Full Text] [Related]
26. Antagonism of quinpirole by (+)-AJ 76: possible involvement of D3 receptors.
Gui-Hua C; Woolverton WL
Eur J Pharmacol; 1991 Dec; 209(3):285-6. PubMed ID: 1686769
[No Abstract] [Full Text] [Related]
27. Differential regional and cellular distribution of dopamine D2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain.
Khan ZU; Gutiérrez A; Martín R; Peñafiel A; Rivera A; De La Calle A
J Comp Neurol; 1998 Dec; 402(3):353-71. PubMed ID: 9853904
[TBL] [Abstract][Full Text] [Related]
28. Differential pharmacological profile of striatal and cerebellar dopamine receptors labeled by [3H]quinpirole: identification of a discrete population of putative D3 receptors.
Levant B; DeSouza EB
Synapse; 1993 May; 14(1):90-5. PubMed ID: 8099762
[TBL] [Abstract][Full Text] [Related]
29. The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice.
Ralph RJ; Varty GB; Kelly MA; Wang YM; Caron MG; Rubinstein M; Grandy DK; Low MJ; Geyer MA
J Neurosci; 1999 Jun; 19(11):4627-33. PubMed ID: 10341260
[TBL] [Abstract][Full Text] [Related]
30. Dopamine D2-like receptor agonists induce penile erection in male rats: differential role of D2, D3 and D4 receptors in the paraventricular nucleus of the hypothalamus.
Sanna F; Succu S; Hübner H; Gmeiner P; Argiolas A; Melis MR
Behav Brain Res; 2011 Nov; 225(1):169-76. PubMed ID: 21784104
[TBL] [Abstract][Full Text] [Related]
31. Dopamine receptors modulate T lymphocytes via inhibition of cAMP-CREB signaling pathway.
Huang Y; Chen CC; Wang TT; Qiu YH; Peng YP
Neuro Endocrinol Lett; 2016 Dec; 37(7):491-500. PubMed ID: 28326743
[TBL] [Abstract][Full Text] [Related]
32. Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization.
Bates MD; Senogles SE; Bunzow JR; Liggett SB; Civelli O; Caron MG
Mol Pharmacol; 1991 Jan; 39(1):55-63. PubMed ID: 1846220
[TBL] [Abstract][Full Text] [Related]
33. Dopamine D
García-Pedraza JÁ; Morán A; Martín ML; Ollauri-Ibáñez C; Rodríguez-Barbero A; Villalón CM; García-Domingo M
Pflugers Arch; 2020 Dec; 472(12):1693-1703. PubMed ID: 32820344
[TBL] [Abstract][Full Text] [Related]
34. Participation of prostaglandin E2 in dopamine D2 receptor-dependent potentiation of arachidonic acid release.
Di Marzo V; Piomelli D
J Neurochem; 1992 Jul; 59(1):379-82. PubMed ID: 1351931
[TBL] [Abstract][Full Text] [Related]
35. Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons.
Bono F; Savoia P; Guglielmi A; Gennarelli M; Piovani G; Sigala S; Leo D; Espinoza S; Gainetdinov RR; Devoto P; Spano P; Missale C; Fiorentini C
Mol Neurobiol; 2018 Feb; 55(2):1054-1067. PubMed ID: 28092083
[TBL] [Abstract][Full Text] [Related]
36. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
37. Expression and functional characterisation of a synthetic version of the human D4 dopamine receptor in a stable human cell line.
McHale M; Coldwell MC; Herrity N; Boyfield I; Winn FM; Ball S; Cook T; Robinson JH; Gloger IS
FEBS Lett; 1994 May; 345(2-3):147-50. PubMed ID: 8200447
[TBL] [Abstract][Full Text] [Related]
38. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
39. Opposite effects of dopamine D2 and D3 receptors on learning and memory in the rat.
Sigala S; Missale C; Spano P
Eur J Pharmacol; 1997 Oct; 336(2-3):107-12. PubMed ID: 9384221
[TBL] [Abstract][Full Text] [Related]
40. Dopamine D3 receptors in rat juxtaglomerular cells.
Sanada H; Yao L; Jose PA; Carey RM; Felder RA
Clin Exp Hypertens; 1997; 19(1-2):93-105. PubMed ID: 9028638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
